Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03192345 |
|---|---|
| Brief Title: | A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid Tumors |
| First Submitted : | June 16, 2017 |
| First Submitted that Met QC Criteria : | June 16, 2017 |
| First Posted : | June 20, 2017 |
| Last Update Submitted that Met QC Criteria : | May 11, 2022 |
| Last Update Posted : | May 12, 2022 |